ARTICLE | Clinical News
Cantab cocaine addiction study on hold
September 6, 2000 7:00 AM UTC
Cantab (LSE:CTB; CNTBY) said vaccinations in its Phase IIa study of TA-CD cocaine derivative coupled with rCTB carrier protein and formulated with alum are on hold due to an adverse event observed in ...